Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SRx Health Solutions (SRXH) Gross Margin (2016 - 2025)

SRx Health Solutions (SRXH) has disclosed Gross Margin for 10 consecutive years, with 25.06% as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Gross Margin rose 300.0% year-over-year to 25.06%, compared with a TTM value of 96.93% through Jun 2025, up 7243.0%, and an annual FY2024 reading of 57.82%, up 2725.0% over the prior year.
  • Gross Margin was 25.06% for Q2 2025 at SRx Health Solutions, down from 33.29% in the prior quarter.
  • Across five years, Gross Margin topped out at 308.36% in Q4 2024 and bottomed at 9.33% in Q4 2023.
  • Average Gross Margin over 5 years is 45.38%, with a median of 33.45% recorded in 2025.
  • Peak annual rise in Gross Margin hit 29903bps in 2024, while the deepest fall reached -1199bps in 2024.
  • Year by year, Gross Margin stood at 25.08% in 2021, then fell by -28bps to 17.94% in 2022, then tumbled by -48bps to 9.33% in 2023, then soared by 3205bps to 308.36% in 2024, then crashed by -92bps to 25.06% in 2025.
  • Business Quant data shows Gross Margin for SRXH at 25.06% in Q2 2025, 33.29% in Q1 2025, and 308.36% in Q4 2024.